Failure to demonstrate contrast nephrotoxicity. 1991

C A Heller, and J Knapp, and J Halliday, and D O'Connell, and R F Heller
Department of Radiology, Royal Newcastle Hospital, NSW.

OBJECTIVE We tested the hypothesis that there is no difference in the change in serum creatinine level following computed tomography (CT) between those given high osmolality contrast, low osmolality contrast and those not receiving contrast material. METHODS Patients were assigned according to current radiological practice to receive one or other type of radiocontrast material or to have a scan without intravenous contrast (plain scan). METHODS The CT unit of Royal Newcastle Hospital, a tertiary referral institution. METHODS Of 3188 inpatients having a CT scan between June 1988 and December 1989, 1041 patients were eligible (having a first scan in "office hours" outside holiday periods, not due for imminent discharge, aged 18 years or more and not presenting to the Intensive Care Unit or with acute trauma). Twenty-five patients were excluded as baseline measures of renal function were missing and 132 subjects were lost to follow-up, leaving 884 study subjects. METHODS CT scans using high osmolality, low osmolality or no contrast (plain scan). METHODS Renal impairment as defined by a maximal increase in the serum creatinine level of greater than or equal to 50% or greater than 0.04 mmol/L from the baseline level on at least one of the subsequent four days. RESULTS Renal impairment was seen in 4% (12 of 292), 12% (23 of 187) and 4% (16 of 405) of patients given high osmolality, low osmolality or no contrast respectively. Age and the baseline level of serum creatinine were independent predictors of the development of renal impairment (P = 0.04 and 0.02 respectively) and those given low osmolality contrast were 3.2 times (95% confidence interval, 1.6-6.3) more likely to develop renal impairment than those given no contrast. There was no excess risk with the use of high osmolality contrast compared to no contrast (odds ratio, 1.06; 95% confidence interval, 0.5-2.3). Selection factors (sicker patients being given low osmolality contrast) are likely to have accounted for the excess risk in the low osmolality group as mortality in hospital was higher in this group than in the others. The 51 patients who developed renal impairment (cases) were matched for age, sex, type of contrast and pre-existing renal impairment with up to three controls (150 patients in total). Cases were more likely to have had a blood transfusion (odds ratio, 6.40; 95% confidence interval, 2.18-22.63) or surgery (odds ratio, 3.22; 95% confidence interval, 1.19-7.65) than controls. CONCLUSIONS Confounding by other factors which impair renal function is likely to explain previous suggestions of an effect of radio-contrast material on renal function. There does not appear to be a risk of renal impairment from the use of high osmolality radiocontrast material (although a small effect or an effect in particular subgroups cannot be excluded by our study). Fear of causing or exacerbating renal damage should not be a reason to use low osmolality contrast material, nor should it be a reason for with-holding contrast studies.

UI MeSH Term Description Entries
D007479 Iopamidol A non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiological procedures. B-15,000,B-15000,Gastromiro,Iopamidol, (+-)-Isomer,Iopamidol, (R)-Isomer,Iopamidol, Sodium Salt, (S)-Isomer,Iopamiro,Isovue,Isovue 370,Jopamidol,Niopam,SQ 13,396,Solutrast,Solutrast 370,Solutrast Gastro,B 15,000,B 15000,B15,000,B15000
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D008297 Male Males
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D001803 Blood Transfusion The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed) Blood Transfusions,Transfusion, Blood,Transfusions, Blood
D003287 Contrast Media Substances used to allow enhanced visualization of tissues. Radiopaque Media,Contrast Agent,Contrast Agents,Contrast Material,Contrast Materials,Radiocontrast Agent,Radiocontrast Agents,Radiocontrast Media,Agent, Contrast,Agent, Radiocontrast,Agents, Contrast,Agents, Radiocontrast,Material, Contrast,Materials, Contrast,Media, Contrast,Media, Radiocontrast,Media, Radiopaque
D003401 Creatine An amino acid that occurs in vertebrate tissues and in urine. In muscle tissue, creatine generally occurs as phosphocreatine. Creatine is excreted as CREATININE in the urine.
D003973 Diatrizoate A commonly used x-ray contrast medium. As DIATRIZOATE MEGLUMINE and as Diatrizoate sodium, it is used for gastrointestinal studies, angiography, and urography. Amidotrezoate,Amidotrizoate,Benzoic acid, 3,5-bis(acetylamino)-2,4,6-triiodo-,Diatrizoate Sodium,Diatrizoic Acid,Hypaque,Hypaque 50,Sodium Diatrizoate,Sodium-Magnesium Diatrizoate,Urogranoic Acid,Urothrast,Urotrast,Diatrizoate, Sodium,Diatrizoate, Sodium-Magnesium
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

C A Heller, and J Knapp, and J Halliday, and D O'Connell, and R F Heller
January 1992, The Medical journal of Australia,
C A Heller, and J Knapp, and J Halliday, and D O'Connell, and R F Heller
March 1972, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
C A Heller, and J Knapp, and J Halliday, and D O'Connell, and R F Heller
October 2000, Scandinavian journal of urology and nephrology,
C A Heller, and J Knapp, and J Halliday, and D O'Connell, and R F Heller
August 1994, Journal of the American Society of Nephrology : JASN,
C A Heller, and J Knapp, and J Halliday, and D O'Connell, and R F Heller
August 1989, The New England journal of medicine,
C A Heller, and J Knapp, and J Halliday, and D O'Connell, and R F Heller
December 1984, Neuropeptides,
C A Heller, and J Knapp, and J Halliday, and D O'Connell, and R F Heller
March 1996, Current opinion in nephrology and hypertension,
C A Heller, and J Knapp, and J Halliday, and D O'Connell, and R F Heller
October 2005, Deutsche medizinische Wochenschrift (1946),
C A Heller, and J Knapp, and J Halliday, and D O'Connell, and R F Heller
January 1997, Seminars in nephrology,
C A Heller, and J Knapp, and J Halliday, and D O'Connell, and R F Heller
February 1998, AJR. American journal of roentgenology,
Copied contents to your clipboard!